Antimony-containing Substances Group

These substances were identified for action under the Chemicals Management Plan (CMP). 


Summary of publications
Substance group CAS RN Common name DSL name Public comments received on the draft screening assessment Final screening assessment Conclusion on section 64 criteria Follow-up activities
Antimony-containing Substance Group 1314-60-9 Antimony pentoxide Antimony oxide (Sb2O5) HTML HTML Does not meet None planned at this time
1327-33-9a Antimony oxide Antimony oxide
1345-04-6 Antimony sulfide Antimony sulfide (Sb2S3)
10025-91-9 Antimony trichloride Stibine, trichloro-
15432-85-6 Sodium antimonate Antimonate (SbO31-), sodium
15874-48-3 NA Phosphorodithioic acid, O,O-dipropyl ester, antimony(3+) salt
15890-25-2 Antimony diamyldithiocarbamate Antimony, tris(dipentylcarbamodithioato-S,S')-, (OC-6-11)-
15991-76-1 NA Antimony, tris[bis(2-ethylhexyl)carbamodithioato-S,S']-, (OC-6-11)-
28300-74-5 Antimony potassium tartrate (APT) Antimonate(2-), bis[µ-[2,3-di(hydroxy-κO)butanedioato(4-)-κO1:κO4]]di-, dipotassium, trihydrate, stereoisomer
29638-69-5 Potassium antimonate Antimonate (Sb2O74-), tetrapotassium
33908-66-6 Sodium hexahydroxoantimonate Antimonate (Sb(OH)61-), sodium, (OC-6-11)-
Date Activity
July 11, 2020 Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol 154, No. 28.
September 15, 2018 Publication and start of 60-day public comment period on the draft screening assessment.  The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 37.

Page details

Date modified: